Literature DB >> 14971804

Lack of appropriate formulations of medicines for children in the community.

E Schirm1, H Tobi, T W de Vries, I Choonara, L T W De Jong-van den Berg.   

Abstract

AIM: Appropriate formulations are essential in pharmacotherapy. This study surveyed the use of different formulations by children in the community, and examined the reported lack of appropriate formulations (oral solutions) in relation to the licensing status of drugs.
METHODS: A cross-sectional study based on 68,019 pharmacy dispensing records was performed in The Netherlands. For each prescription the formulation was assessed, and all prescriptions were categorized: unlicensed (no product licence), off-label (licensed drugs used outside the licence terms) and authorized (licensed drugs used according to the licence). The types of formulation used were assessed in relation to age and licensing status.
RESULTS: In all age groups, approximately half of all prescriptions were for oral drugs. The only major age-related trend was within oral drugs: younger children were more likely to be prescribed oral solutions. For authorized drugs the proportion of tablet/capsules exceeded oral solutions at the age of 7 y, whereas for off-label drugs this occurred at 3 y of age. For those medicines prepared by the pharmacy, tablets and capsules were more likely to be prescribed from the age of 9 y.
CONCLUSION: Many children in the community receive inappropriate oral formulations. Regulatory authorities and the pharmaceutical industry need to ensure that children have access to medicines with appropriate formulations.

Entities:  

Mesh:

Year:  2003        PMID: 14971804     DOI: 10.1080/08035250310006728

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  26 in total

1.  Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.

Authors:  Rajan Ragupathy; June Tordoff; Pauline Norris; David Reith
Journal:  Pharm World Sci       Date:  2010-03-31

2.  Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing.

Authors:  Tareq L Mukattash; Mayyada Wazaify; Najwa Khuri-Boulos; Anan Jarab; Ahmed F Hawwa; James C McElnay
Journal:  Int J Clin Pharm       Date:  2011-09-28

3.  Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.

Authors:  Komathi Balakrishnan; June Tordoff; Pauline Norris; David Reith
Journal:  Br J Clin Pharmacol       Date:  2006-07-26       Impact factor: 4.335

4.  The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.

Authors:  Federico Marchetti; Jenny Bua; Alessandro Ventura; Luigi D Notarangelo; Salvatore Di Maio; Giuseppina Migliore; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

5.  When do children convert from liquid antiretroviral to solid formulations?

Authors:  Vincent W Yeung; Ian C K Wong
Journal:  Pharm World Sci       Date:  2005-10

6.  Three years of paediatric regulation in the European Union.

Authors:  Thorsten M Olski; Simona F Lampus; Giulia Gherarducci; Agnes Saint Raymond
Journal:  Eur J Clin Pharmacol       Date:  2011-02-01       Impact factor: 2.953

7.  Pharmacovigilance for children's sake.

Authors:  Kristina Star; I Ralph Edwards
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 8.  The bad taste of medicines: overview of basic research on bitter taste.

Authors:  Julie A Mennella; Alan C Spector; Danielle R Reed; Susan E Coldwell
Journal:  Clin Ther       Date:  2013-07-22       Impact factor: 3.393

9.  Solid oral forms availability in children: a cost saving investigation.

Authors:  Audrey Lajoinie; Emilie Henin; Behrouz Kassai; David Terry
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

10.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.